Supernus Pharmaceuticals (SUPN) Gross Profit (2013 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Gross Profit of $185.4 million for Q2 2026, up 24.74% year-over-year from $148.6 million in Q2 2025, and down 1.68% on a QoQ basis from $188.6 million in Q4 2025.
Supernus Pharmaceuticals (SUPN) Gross Profit (2013 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Gross Profit for 14 years, with the latest figure at $185.4 million in Q2 2026.
- Gross Profit for Q2 2026 came in at $185.4 million, up 24.74% year-over-year; the trailing twelve-month figure through Jun 2026 was $695.7 million (up 18.15% YoY), and the FY2025 annual result was $644.4 million, up 10.36% from the prior year.
- Gross Profit fell to $185.4 million in Q2 2026, from $188.6 million in the prior quarter.
- Over five years, Gross Profit peaked at $188.6 million in Q4 2025 and troughed at $114.5 million in Q2 2023.
- A 5-year average of $148.1 million and a median of $148.1 million in 2024 frame the typical range for Gross Profit.
- The widest annual swing landed in 2023, when Gross Profit decreased 23.48%; it then soared 31.39% in 2024.
- A 5-year view of Gross Profit shows it stood at $144.4 million in 2022, then advanced by 0.22% to $144.7 million in 2023, then rose by 2.33% to $148.1 million in 2024, then climbed by 27.36% to $188.6 million in 2025, then fell by 1.68% to $185.4 million in 2026.
- Per Business Quant data, the three most recent Gross Profit figures were $185.4 million in Q2 2026, $188.6 million in Q4 2025, and $173.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 185.39 Mn |
| Jun 30, 2026 | 185.39 Mn |
| Dec 31, 2025 | 188.57 Mn |
| Dec 31, 2025 | 188.57 Mn |
| Sep 30, 2025 | 173.14 Mn |
| Sep 30, 2025 | 173.14 Mn |
| Jun 30, 2025 | 148.63 Mn |
| Jun 30, 2025 | 148.63 Mn |
| Mar 31, 2025 | 134.06 Mn |
| Mar 31, 2025 | 134.06 Mn |
| Dec 31, 2024 | 148.06 Mn |
| Dec 31, 2024 | 148.06 Mn |
| Sep 30, 2024 | 158.11 Mn |
| Sep 30, 2024 | 158.11 Mn |
| Jun 30, 2024 | 150.41 Mn |
| Jun 30, 2024 | 150.41 Mn |
| Mar 31, 2024 | 127.34 Mn |
| Mar 31, 2024 | 127.34 Mn |
| Dec 31, 2023 | 144.69 Mn |
| Dec 31, 2023 | 144.69 Mn |